Submission for OMB Review; 30-day Comment Request, U.S. Nuclear Medicine Technologists Study (NCI), 36553-36554 [2016-13308]
Download as PDF
<![CDATA[
36553
Federal Register / Vol. 81, No. 109 / Tuesday, June 7, 2016 / Notices
Effectiveness Trials for Treatment, Preventive
and Services Interventions (R34)
Date: June 24, 2016.
Time: 11:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Karen Gavin-Evans, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Boulevard, Room 6153, MSC
9606, Bethesda, MD 20892, 301–451–2356,
gavinevanskm@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Fellowship and Dissertation Grants Review
Meeting.
Date: June 30, 2016.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Mental Health Services Conflicts
(Teleconference).
Date: June 30, 2016.
Time: 12:30 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Karen Gavin-Evans, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Boulevard, Room 6153, MSC
9606, Bethesda, MD 20892, 301–451–2356,
gavinevanskm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: June 1, 2016.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact*: Michele M. Doody, Radiation
Epidemiology Branch, National Cancer
Institute, 9609 Medical Center Drive,
Room 7E566, Rockville, MD 20850, or
call non-toll-free number 301–414–
0308. Or Email your request, including
your address to: doodym@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: U.S. Nuclear
Medicine Technologists Study, 0925–
0656, Expiration Date 04/30/2015—
REINSTATEMENT WITH CHANGE,
National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection: We propose to collect from
U.S. nuclear medicine technologists
(USNMT) certified after 1980 historical
information about nuclear medicine
procedures performed, radioisotopes
used, related work and safety practices,
and places of employment. The primary
objectives of the current feasibility effort
are: (a) To identify a cohort of nuclear
medicine technologists certified after
1980 by the American Registry of
Radiologic Technologists (ARRT) and/or
the Nuclear Medicine Technologist
Certification Board (NMTCB); and (b) to
characterize individual organ-specific
occupational radiation doses from
radioisotope procedures. More recently
certified technologists, who specialized
in nuclear medicine, are expected to
have greater exposures to radioisotopes
than the general radiologic technologists
in the U.S. Radiologic Technologist
(USRT) cohort owing to performing
such procedures with greater frequency.
The proposed USNMT study would be
a direct follow-on to the USRT Study to
assess health risks associated with
occupational exposure to these much
higher-energy radiopharmaceuticals.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
125.
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2016–13310 Filed 6–6–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-day
Comment Request, U.S. Nuclear
Medicine Technologists Study (NCI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Institute, the National Institutes
of Health, has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on March 28, 2016 and allowed
60-days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Cancer Institute, National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
SUMMARY:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Frequency of
response
Average time
per response
(hours)
Annual hour
burden
Type of respondent
Instrument
Nuclear Medicine Technologists .......
Nuclear Medicine Questionnaire ......
250
1
30/60
125
Total ...........................................
...........................................................
250
250
........................
125
VerDate Sep<11>2014
19:13 Jun 06, 2016
Jkt 238001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
E:\FR\FM\07JNN1.SGM
07JNN1
36554
Federal Register / Vol. 81, No. 109 / Tuesday, June 7, 2016 / Notices
Dated: May 31, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.
Committee Name: Substance Abuse
and Mental Health Services,
Administration Center for Substance
Abuse Prevention National Advisory
Council.
Date/Time/Type: June 13, 2016, 1:30
p.m.–2:30 p.m. (CLOSED).
Place: SAMHSA Building, 5600
Fishers Lane, Rockville, MD 20857.
Contact: Matthew J. Aumen,
Designated Federal Officer, SAMHSA/
CSAP National Advisory Council, 5600
Fishers Lane, Rockville, MD 20857,
Email: Matthew.Aumen@
samhsa.hhs.gov.
[FR Doc. 2016–13308 Filed 6–6–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, June
23, 2016, 08:00 a.m. to June 24, 2016,
06:00 p.m., Doubletree Hotel Bethesda,
8120 Wisconsin Avenue, Bethesda, MD,
20814 which was published in the
Federal Register on May 16, 2016, 81
FR 30318.
The meeting notice is amended to
change the Committee name from
National Cancer Institute, Special
Emphasis Panel; NCI Omnibus R03
SEP–1 to National Cancer Institute,
Special Emphasis Panel; NCI R03 SEP–
2. The meeting is closed to the public.
Dated: June 1, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–13309 Filed 6–6–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention
(CSAP) National Advisory Council will
meet on June 13, 2016, 1:30 p.m.–2:30
p.m., via teleconference.
The meeting will include the review,
discussion, and evaluation of grant
applications reviewed by the Initial
Review Group, and involve an
examination of confidential financial
and business information as well as
personal information concerning the
applicants. Therefore, these meetings
will be closed to the public as
determined by the SAMHSA
Administrator, in accordance with Title
5 U.S.C. 552b(c)(4) and (c)(6); and 5
U.S.C. App. 2, Section 10(d).
VerDate Sep<11>2014
19:13 Jun 06, 2016
Jkt 238001
Summer King,
Statistician, SAMHSA.
[FR Doc. 2016–13369 Filed 6–6–16; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Protection and Advocacy for
Individuals With Mental Illness
(PAIMI) Final Rule, 42 CFR Part 51
(OMB No. 0930–0172)—Extension
These regulations meet the directive
under 42 U.S.C. 10826(b) requiring the
Secretary to promulgate final
regulations to carry out the PAIMI Act.
The regulations contain information
collection requirements. The Act
authorizes funds to support activities on
behalf of individuals with significant
(severe) mental illness (adults) or
significant (severe) emotional
impairment (children/youth) as defined
by 42 U.S.C. 10802(4) and 10804(d).
Only entities designated by the governor
of each State, including American
Samoa, Guam, the Commonwealth of
the Northern Mariana Islands, the
Commonwealth of Puerto Rico, the U.S.
Virgin Islands, the Mayor of the District
of Columbia, and the tribal councils for
the American Indian Consortium (the
Hopi and Navajo Nations in the Four
Corners region of the Southwest), to
protect and advocate the rights of
persons with developmental disabilities
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
are eligible to receive PAIMI Program
grants [the Act at 42 U.S.C. at 10802(2)].
These grants are based on a formula
prescribed by the Secretary [42 U.S.C. at
10822(a)(1)(A)].
On January 1, each eligible state
protection and advocacy (P&A) system
is required to prepare a report that
describes its activities,
accomplishments, and expenditures to
protect the rights of individuals with
mental illness supported with payments
from PAIMI Program allotments during
the most recently completed fiscal year.
The PAIMI Act at 42 U.S.C. 10824(a)
requires that each P&A system transmit
a copy of its annual report to the
Secretary (via SAMHSA/CMHS) and to
the State Mental Health Agency where
the system is located. These annual
PAIMI Program Performance Reports
(PPR) to the Secretary must include the
following information:
• The number of (PAIMI-eligible)
individuals with mental illness served;
• A description of the types of
activities undertaken;
• A description of the types of
facilities providing care or treatment to
which such activities are undertaken;
• A description of the manner in
which the activities are initiated;
• A description of the
accomplishments resulting from such
activities;
• A description of systems to protect
and advocate the rights of individuals
with mental illness supported with
payments from PAIMI Program
allotments;
• A description of activities
conducted by States to protect and
advocate such rights;
• A description of mechanisms
established by residential facilities for
individuals with mental illness to
protect such rights; and,
• A description of the coordination
among such systems, activities and
mechanisms;
• Specification of the number of
public and nonprofit P&A systems
established with PAIMI Program
allotments;
• Recommendations for activities and
services to improve the protection and
advocacy of the rights of individuals
with mental illness and a description of
the need for such activities and services
that were not met by the State P&A
systems established under the PAIMI
Act due to resource or annual program
priority limitations.
The PAIMI Rules [42 CFR part 51]
mandate that each State P&A system
may place restrictions on either its case
or client acceptance criteria developed
as part of its annual PAIMI priorities.
Each P&A system is required to inform
E:\FR\FM\07JNN1.SGM
07JNN1
]]>Agencies
[Federal Register Volume 81, Number 109 (Tuesday, June 7, 2016)]
[Notices]
[Pages 36553-36554]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13308]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-day Comment Request, U.S. Nuclear
Medicine Technologists Study (NCI)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Cancer Institute, the National
Institutes of Health, has submitted to the Office of Management and
Budget (OMB) a request for review and approval of the information
collection listed below. This proposed information collection was
previously published in the Federal Register on March 28, 2016 and
allowed 60-days for public comment. No public comments were received.
The purpose of this notice is to allow an additional 30 days for public
comment. The National Cancer Institute, National Institutes of Health,
may not conduct or sponsor, and the respondent is not required to
respond to, an information collection that has been extended, revised,
or implemented on or after October 1, 1995, unless it displays a
currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, or request more information on the
proposed project, contact*: Michele M. Doody, Radiation Epidemiology
Branch, National Cancer Institute, 9609 Medical Center Drive, Room
7E566, Rockville, MD 20850, or call non-toll-free number 301-414-0308.
Or Email your request, including your address to: doodym@mail.nih.gov.
Formal requests for additional plans and instruments must be requested
in writing.
Proposed Collection: U.S. Nuclear Medicine Technologists Study,
0925-0656, Expiration Date 04/30/2015--REINSTATEMENT WITH CHANGE,
National Cancer Institute (NCI), National Institutes of Health (NIH).
Need and Use of Information Collection: We propose to collect from
U.S. nuclear medicine technologists (USNMT) certified after 1980
historical information about nuclear medicine procedures performed,
radioisotopes used, related work and safety practices, and places of
employment. The primary objectives of the current feasibility effort
are: (a) To identify a cohort of nuclear medicine technologists
certified after 1980 by the American Registry of Radiologic
Technologists (ARRT) and/or the Nuclear Medicine Technologist
Certification Board (NMTCB); and (b) to characterize individual organ-
specific occupational radiation doses from radioisotope procedures.
More recently certified technologists, who specialized in nuclear
medicine, are expected to have greater exposures to radioisotopes than
the general radiologic technologists in the U.S. Radiologic
Technologist (USRT) cohort owing to performing such procedures with
greater frequency. The proposed USNMT study would be a direct follow-on
to the USRT Study to assess health risks associated with occupational
exposure to these much higher-energy radiopharmaceuticals.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 125.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average time
Type of respondent Instrument Number of Frequency of per response Annual hour
respondents response (hours) burden
----------------------------------------------------------------------------------------------------------------
Nuclear Medicine Technologists Nuclear Medicine 250 1 30/60 125
Questionnaire.
---------------------------------------------------------------
Total..................... ................ 250 250 .............. 125
----------------------------------------------------------------------------------------------------------------
[[Page 36554]]
Dated: May 31, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer Institute, NIH.
[FR Doc. 2016-13308 Filed 6-6-16; 8:45 am]
BILLING CODE 4140-01-P
